NASDAQ:PKBO Peak Bio (PKBO) Stock Price, News & Analysis $0.0096 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.0096▼$0.009650-Day Range$0.0086▼$0.009652-Week Range$0.00▼$0.85VolumeN/AAverage Volume3 shsMarket Capitalization$221,952.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends Get Peak Bio alerts: Email Address Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Peak Bio Stock (NASDAQ:PKBO)Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with inflammatory, cancer, and rare and specialty diseases. The company's lead product candidate is PHP-303, which is in phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome. It also develops Trop2 PH1, an antibody-drug-conjugate for solid tumors. The company was founded in 2020 and is based in Pleasanton, California.Read More PKBO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PKBO Stock News HeadlinesJuly 17, 2024 | americanbankingnews.comReviewing Peak Bio (NASDAQ:PKBO) and Turnstone Biologics (NASDAQ:TSBX)May 25, 2024 | msn.comThe inspiring name behind Piestewa Peak: meet the first native woman to die in combatJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 1, 2024 | globenewswire.comAkari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger EntityApril 11, 2024 | msn.comOppenheimer starts Q32 Bio at outperform, cites lead assetMarch 6, 2024 | msn.comAkari Therapeutics enters merger deal with Peak BioMarch 5, 2024 | prnewswire.comShareholder Alert: Ademi LLP investigates whether Peak Bio Inc. has obtained a Fair Price in its transaction with AkariMarch 5, 2024 | globenewswire.comAkari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) ToolkitJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.February 17, 2024 | benzinga.comPyramid Peak Foundation's Net WorthFebruary 7, 2024 | markets.businessinsider.comPeak Bio Raises Capital via Convertible Promissory NotesJanuary 4, 2024 | finance.yahoo.comPeak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA SplicingDecember 12, 2023 | businessinsider.comWhen to watch the spectacular Geminid meteor shower this week. NASA says skies are ideal for viewing it.September 19, 2023 | finance.yahoo.comPeak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicingSeptember 14, 2023 | finance.yahoo.comInsider Buying: Hoyoung Huh Acquires 47,000 Shares of Peak Bio Inc (PKBO)August 31, 2023 | theglobeandmail.comBioPharma Uplists to OTCQBAugust 31, 2023 | benzinga.comPeak Bio, Inc. Announces Up-listing to OTCQB MarketAugust 31, 2023 | finance.yahoo.comPeak Bio, Inc., Announces Appointment of Michael Friedman to Board of DirectorsSee More Headlines Receive PKBO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Peak Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/24/2024Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:PKBO CUSIPN/A CIK1834645 Webpeak-bio.com Phone650-549-9103FaxN/AEmployees21Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$610,000.00 Price / Sales0.36 Cash FlowN/A Price / Cash FlowN/A Book Value($0.40) per share Price / Book-0.02Miscellaneous Outstanding Shares23,120,000Free Float18,523,000Market Cap$221,952.00 OptionableNot Optionable Beta0.16 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Hoyoung Huh M.D. (Age 55)Ph.D., Executive Chairman (Leave of Absence) Comp: $1.67MDr. Stephen LaMond M.B.A. (Age 62)Pharm.D., PharmD MBA, Interim CEO, COO, Secretary & Director Comp: $499.17kDr. Satyajit Mitra Ph.D. (Age 50)Head of Oncology & Executive Director Comp: $317.22kMs. Moddy WongDirector of Human ResourcesMs. Divya PatelController & TreasurerKey CompetitorsAcorda TherapeuticsNASDAQ:ACORQGenocea BiosciencesNASDAQ:GNCAAlvotechNASDAQ:ALVOGenocea BiosciencesNASDAQ:GNCAQOppFiNYSE:OPFIView All Competitors PKBO Stock Analysis - Frequently Asked Questions How have PKBO shares performed this year? Peak Bio's stock was trading at $0.1875 on January 1st, 2024. Since then, PKBO stock has decreased by 94.9% and is now trading at $0.0096. View the best growth stocks for 2024 here. How were Peak Bio's earnings last quarter? Peak Bio, Inc. (NASDAQ:PKBO) released its earnings results on Monday, June, 24th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm earned $0.28 million during the quarter. How do I buy shares of Peak Bio? Shares of PKBO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PKBO) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Peak Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Peak Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.